May 24, 2011
Intrinsic Imaging Joins Metastatic Colorectal Cancer Trial
Five-year multicenter clinical trial in metastatic colorectal cancer.
Download the PDFMay 24, 2011 — Biopharmaceutical medical imaging services firm Intrinsic Imaging will be participating in a five-year multicenter clinical trial related to the treatment of metastatic colorectal cancer.
The San Antonio-based firm said it would provide imaging core lab services to manage acquisition, transfer, and processing of images from hundreds of patients from more than 40 investigator sites. Intrinsic will also provide its team of oncology-subspecialized radiologists for image interpretation during the trial.
About Intrinsic Imaging, LLC
Intrinsic Imaging is a full-service medical imaging core lab providing comprehensive services in support of Phase I-IV clinical trials and Class I, II, III medical device trials. Intrinsic Imaging is also a world leader in conducting Artificial Intelligence studies. With its team of more than 750 board-certified and fellowship-trained physicians, Intrinsic Imaging’s team has sub-specialization in all therapeutic areas, including Cardiovascular, Central Nervous System, Gastroenterology, Musculoskeletal, Oncology and Ophthalmology. Certified by the British Standards Institution (BSI), Intrinsic Imaging is the only company in the world to hold five ISO certifications specifically for providing imaging core lab services on clinical trials. For more information, please visit www.IntrinsicImaging.com.
Get Our Announcements by Email
Receive Intrinsic Imaging press releases as soon as they are issued.
Contact:
- Intrinsic Imaging, LLC
- 580 Main St., Suite 210
- Bolton, MA, 01740, USA
- +1 978-616-4650
- Contact@IntrinsicImaging.com